JULIANNA CONNIFF: Open Payments
NPI 1326424920 · WILKES BARRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 9 payments from 6 companies in 2025. Trend: 2023 $163 · 2024 $449 · 2025 $250
Food & beverage: $170Education: $80
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 1 | $80 |
| Amgen Inc. | 3 | $57 |
| SCPHARMACEUTICALS INC. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
Products named: OPSUMIT, REPATHA, FUROSCIX, VERQUVO, Wegovy.
Industry payments across PA — which companies pay providers there.
